Effect Evaluation of Independent Medical Evaluation (IME) in Norway (NIME)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02524392|
Recruitment Status : Completed
First Posted : August 14, 2015
Last Update Posted : May 11, 2018
|Condition or disease||Intervention/treatment||Phase|
|All International Classification of Primary Care 2 Diagnoses||Other: Independent medical evaluation||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||7642 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Effect Evaluation of Independent Medical Evaluation (IME) After Six Months Sick Leave: A Randomized Controlled Trial of Independent Medical Evaluation (IME) Versus Treatment as Usual in Norway|
|Actual Study Start Date :||September 2015|
|Actual Primary Completion Date :||February 2018|
|Actual Study Completion Date :||March 2018|
Experimental: Independent medical evaluation
Independent medical evaluation (IME) of another doctor than the treating general practitioner.
Other: Independent medical evaluation
The independent medical evaluation (IME) will be performed by specialists in general medicine, temporarily hired by the county welfare service. The independent medical evaluation (IME) procedure is developed by the Research Unit for General Practice at Uni Research Health in Norway.
No Intervention: Treatment as usual
Treatment as usual by the treating general practitioner. There will be one randomized control group in one county. Sick-listed in other counties serve as an extra control group.
- Change in sick leave [ Time Frame: Measured at three and eight weeks after randomization. ]Data on sickness benefits from official registers will be used to measure the primary outcome.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02524392
|Bergen, Norway, 5014|
|Principal Investigator:||Silje Maeland, PhD||Uni Research Health|